NCT06506149View on ClinicalTrials.gov

A Prospective Evaluation of Microwave Ablation (MWA) in the Treatment of Relapsed Graves' Disease

NARecruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

July 4, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

June 30, 2026

Conditions
Graves DiseaseMinimally Invasive TreatmentAblation Treatment
Interventions
DEVICE

Microwave ablation(MWA) device

The device for USG-guided MWA treatment would be performed under USG guidance, aiming to ablate the entire thyroid gland, i.e. the right lobe, left lobe, isthmus and pyramidal lobe.

Trial Locations (1)

00000

RECRUITING

Queen Mary Hospital, Hong Kong

All Listed Sponsors
lead

The University of Hong Kong

OTHER